These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Added benefits of drospirenone for compliance. Foidart JM. Climacteric; 2005 Oct; 8 Suppl 3():28-34. PubMed ID: 16203653 [Abstract] [Full Text] [Related]
10. The acceptability of a novel oral contraceptive containing drospirenone and its effect on well-being. Boschitsch E, Skarabis H, Wuttke W, Heithecker R. Eur J Contracept Reprod Health Care; 2000 Dec; 5 Suppl 3():34-40. PubMed ID: 11246600 [Abstract] [Full Text] [Related]
17. Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers. Oelkers W, Helmerhorst FM, Wuttke W, Heithecker R. Gynecol Endocrinol; 2000 Jun; 14(3):204-13. PubMed ID: 10923282 [Abstract] [Full Text] [Related]
18. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Oelkers WK. Steroids; 1996 Apr; 61(4):166-71. PubMed ID: 8732994 [Abstract] [Full Text] [Related]
19. Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women. Lin SQ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Zhou YZ, Wang ML, Zhu J, Chen SR, Su H, Yang CS, Wang SH, Zhang YZ, Dong XJ. Climacteric; 2011 Aug; 14(4):472-81. PubMed ID: 21469973 [Abstract] [Full Text] [Related]